Infections Deaths in the PLATO Trial
Background Cardiovascular benefits of aggressive dual antiplatelet therapy may be associated with extra risks including bleeding, cancer, and infections discovered first for prasugrel in the TRial to assess Improvement in Therapeutic Outcomes by optimizing platelet InhibitioN with prasugrel (TRITON)...
Enregistré dans:
Auteurs principaux: | , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Georg Thieme Verlag KG
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/21f0efbfbda84e639dc973214dd37e3d |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|